Our News on Newswise

Newswise: MarcellaNunez-SmithMDMHSPROFILE.jpg

Dr. Marcella Nunez-Smith Named Director of Center for Community Engagement and Health Equity for Yale Cancer Center and Smilow Cancer Hospital

Marcella Nunez-Smith, MD, MHS, has been appointed Director of the Center for Community Engagement and Health Equity for Yale Cancer Center (YCC) and Smilow Cancer Hospital (SCH), as well as Chief Health Equity Officer & Deputy Chief Medical Officer,...
10-Jul-2020 6:25 PM EDT Add to Favorites

Newswise: LungSPORErenewal3.jpg

Yale Cancer Center Awarded NIH SPORE Renewal for Lung Cancer Research

Yale Cancer Center researchers were awarded a $11 million grant renewal from the National institutes of Health to fund the Yale Specialized Program of Research Excellence (SPORE) in Lung Cancer.
8-Jul-2020 9:05 PM EDT Add to Favorites

Newswise: MarkusMschenMDPhD.png

Müschen Named Inaugural Director of Center of Molecular and Cellular Oncology at Yale Cancer Center and Yale School of Medicine

Markus Müschen, M.D., Ph.D., has been named the inaugural Director of the Center of Molecular and Cellular Oncology at Yale Cancer Center and Smilow Cancer Hospital. Müschen will also be appointed Arthur H. and Isabel Bunker Professor of Medicine...
8-Jul-2020 9:05 PM EDT Add to Favorites

Newswise: JustinLeBlancMD.jpg

Study Shows Breast Cancer Detected Earlier in States with Expanded Medicaid Coverage

In a new study by Yale Cancer Center, researchers have demonstrated that in states with expanded Medicaid coverage through the Affordable Care Act (ACA) a higher percentage of women with breast cancer had their disease diagnosed at an early stage....
28-Jun-2020 8:00 PM EDT Add to Favorites

Newswise: AlfredLeeMDPhD.jpg

Covid-19 Blood Clotting Cause Identified in Study

New findings led by Yale Cancer Center researchers and experts across several medical specialties at Yale identify a leading mechanism behind the pathophysiology of Covid-19 and pinpoint a biological marker for the mechanism that may aid in treating...
29-Jun-2020 1:15 PM EDT Add to Favorites

Newswise: AlessandroSantinMD3.jpg

Study Validates Combination Therapy for Aggressive Endometrial Cancer

Yale Cancer Center (YCC) scientists have found that combining the targeted drug trastuzumab with chemotherapy significantly improves survival rates for women with a rare, aggressive form of endometrial cancer.
26-Jun-2020 12:45 PM EDT Add to Favorites

Newswise: DanielDiMaioMDPhD.jpg

Yale Scientists Develop a New Experimental Method to Study Infection and Disease, Including COVID-19

Yale Cancer Center scientists have developed a new cell screening method for agents that alter biologic functions. This approach uses thousands of artificial proteins called “traptamers” and may help to answer research questions that are...
8-Jun-2020 2:30 PM EDT Add to Favorites

Newswise: PeterGlazerMDPhD.jpg

Scientists Reveal How Mutations in Metabolism Can Drive Cancers

Yale Cancer Center scientists have identified mutations in metabolite-producing genes as a disruption of DNA repair. These mutation-driven “oncometabolites” may make cells more prone to developing cancer—but also more vulnerable to new cancer...
1-Jun-2020 12:15 PM EDT Add to Favorites


See All News

Our Experts on Newswise

Newswise: MichaelGirardiMDPhD.jpg

Five Ways to Lower Your Skin Cancer Risk

Experts at Yale Cancer Center say unless you take the right precautions, sun exposure (even if you don't get scorched) can damage your skin, causing wrinkles, age spots and even skin cancer.
22-Jun-2018 10:05 AM EDT

Yale Expert Discusses Treatment for Endometrial Cancer

Dr. Alesandro Santin Discusses Treatment for Endometrial Cancer
3-Apr-2018 3:55 PM EDT

Expert Speaks on Utilizing Information Technology to Address Oral Chemotherapy Challenges

Utilizing Information Technology to Address Oral Chemotherapy Challenges
26-Mar-2018 2:05 PM EDT

Newswise: prasanna.jpg

Yale Expert Available to Speak on Medical Marijuana for Children with Cancer

12-Mar-2018 3:05 PM EDT

Newswise: Capture.PNG

Overcoming Resistance to Immunotherapy

For some cancer patients, the road to remission and healing can have its share of speed bumps. That’s particularly true of patients with non-small cell lung cancer (NSCLC) who develop a secondary, or acquired, resistance to immunotherapy, which...
27-Oct-2017 11:50 AM EDT

Daniel P. Petrylak, MD, on Urothelial Carcinoma: Results of the RANGE Trial

6-Oct-2017 3:05 PM EDT

Newswise: LiepingChen.JPG

Yale Expert Wins Prestigious 2017 Warren Alpert Prize

6-Oct-2017 2:05 PM EDT

Newswise: CharlesFuchsMDMPHcasual.jpg

Backed by Yale Cancer Center Research, FDA Approves New Immunotherapy Drug for Stomach Cancer

22-Sep-2017 4:30 PM EDT

See All Experts

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.

About

Yale Cancer Center combines a tradition of innovative cancer treatment and quality care for our patients. A National Cancer Institute (NCI) designated comprehensive cancer center for over 40 years, Yale Cancer Center is one of only 45 Centers in the nation.

Yale Cancer Center is a collaboration between nationally and internationally renowned scientists and physicians at Yale School of Medicine and Smilow Cancer Hospital at Yale-New Haven. This partnership enables the Center to provide the best approaches for prevention, detection, diagnosis, and treatment for cancer.

Experts

Contacts

Anne Doerr
Director of Media Relations

anne.doerr@yale.edu

203-737-2629

Renee Gaudette
Director of Marketing & Public Affairs

renee.gaudette@yale.edu

203-671-8156

Scott Gettinger
Associate Professor of Medicine

scott.gettinger@yale.edu

Emily Montemerlo
Marketing Coordinator

emily.fenton@yale.edu

203-785-4343

Twitter

close
2.31639